Type 2 diabetes is associated with high mortality and morbidity due to atherosclerosis. Biermen (1) estimated that typical risk factors, including blood pressure, cholesterol, and smoking, can account for no more than 30% of excess cardiovascular risk factor in diabetic patients. Thus, other factors seem to play a role in the progression of atherosclerosis in diabetes.

Aortic stiffness measured by pulse- wave velocity (PWV) is shown to be highly predictive of cardiovascular mortality in type 2 diabetic patients (2). While age and blood pressure are shown to be associated with PWV, age and blood pressure alone do not completely account for the abnormalities of aortic stiffness in type 2 diabetic patients.

Tumor necrosis factor (TNF) system activity seems to be associated with the progression of atherosclerosis in type 2 diabetes. Shai et al. (3) demonstrated that soluble TNF receptor 2 (sTNF-R2) is strongly associated with risk of coronary heart disease in type 2 diabetic patients. We showed that sTNF-R1 is associated with albuminuria in type 2 diabetic patients (4). To the best of our knowledge, however, it is unclear whether PWV is associated with TNF system activity in type 2 diabetic patients. The aim of the present study, therefore, was to investigate the relationships between PWV and TNF receptors in type 2 diabetic patients.

Eighty-six nonobese Japanese type 2 diabetic patients were enrolled. Their age, BMI, HbA1c (A1C), systolic and diastolic blood pressure, and serum creatinine were 62.8 ± 1.0 years, 22.8 ± 0.3 kg/m2, 7.0 ± 0.1%, 136 ± 2 mmHg, 82 ± 1 mmHg, and 0.76 ± 0.02 mg/dl, respectively. They had not been treated with insulin. Thirty-four patients were treated with antihypertensive medications. In conjunction with PWV, systolic and diastolic blood pressure, A1C, glucose, lipids, serum creatinine, TNF-α, sTNF-R1, and sTNF-R2 were measured after an overnight fast.

With univariate analysis, PWV was positively correlated to age (r = 0.492, P < 0.001), diabetes duration (r = 0.251, P = 0.021), systolic (r = 0.595, P < 0.001) and diastolic (r = 0.248, P = 0.022) blood pressure, antihypertensive medication (r = 0.268, P = 0.013), and the concentrations of sTNF-R1 (r = 0.354, P = 0.001) and sTNF-R2 (r = 0.415, P < 0.001). Other variables, including TNF-α, were not associated with PWV. Multiple regression analyses showed that PWV was independently predicted by age (F = 15.1), systolic blood pressure (F = 31.6), and sTNF-R2 (F = 5.2), which explained 49.2% of the variability of PWV. Thus, TNF system activity seems to be associated with atherosclerosis in nonobese Japanese type 2 diabetic patients.

1.
Bierman EL: George Lyman Duff Memorial Lecture: Atherogenesis in diabetes.
Arterioscler Thromb
12
:
647
–656,
1992
2.
Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG: Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function?
Circulation
106
:
2085
–2090,
2002
3.
Shai I, Schulze MB, Manson JE, Rexrode KM, Stampfer MJ, Mantzoros C, Hu FB: A prospective study of soluble tumor necrosis factor-α receptor II (sTNF-RII) and risk of coronary heart disease among women with type 2 diabetes.
Diabetes Care
28
:
1376
–1382,
2005
4.
Kawasaki Y, Taniguchi A, Fukushima M, Nakai Y, Kuroe A, Ohya M, Nagasaka S, Yamada Y, Inagaki N, Seino Y: Soluble TNF receptors and albuminuria in non-obese Japanese type 2 diabetic patients.
Horm Metab Res
37
:
617
–621,
2005